HOME >> BIOLOGY >> NEWS
UF Researcher Designs Pill To Control Mosquitoes

ecause they were not digesting, so then we knew we had a diet pill, not a birth control pill.

"Fortunately, now we can synthesize the hormone, so we don't have to use 100,000 ovaries for each batch anymore," Borovsky said.

The synthesized hormone is inexpensive, as is chlorella, which is found and produced worldwide. Chlorella, in fact, turns out to be the perfect ride for the mosquito hormone, because it can be freeze-dried and stored for long periods and then brought back to life as the deadly diet pill.

The mosquito fen-phen is benign environmentally. Unlike DDT and some other pesticides, it does not alter the environment in any way, except for poisoning the larval lunch. Mosquitoes that feed on the hormone-laced chlorella starve to death within 72 hours.

"This is a natural bullet that we can use in the environment because the hormone doesn't stay in the environment," Borovsky said. "The chlorella stops producing the hormone within three weeks."

That's by design, Borovsky said. If the hormone were incorporated into the chlorella genome and chlorella continued to produce the hormone, making it omnipresent in the environment, mosquitoes could become resistant to it. But the hormone sits outside the genome, and after the third division of the chlorella it no longer can be detected.

Of course, Borovsky points out, if mosquitoes become resistant to their own reproductive hormone that could have unknown adverse consequences for them as well.

"We have to stay a step ahead of them or outsmart them all over again," Borovsky said.

In the decade since he began work on the pill, Borovsky has made believers out of even the most ardent doubters.

"Ten years ago, everybody was laughing at us, but now they are taking us seriously," Borovsky said. "Eight years ago, at a Vancouver meeting, a colleague harshly criticized this work. He just did not believe it."

The next step, Borovsky says, is to develop diet pills for infamous agricultural pests. Curren
'"/>

Contact: Cindy Spence
crsp@gnv.ifas.ufl.edu
352-392-1773
University of Florida
2-Dec-1997


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... LUXEMBOURG (PRWEB) , ... August ... ... Luxembourg-based clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with ... of enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed ... Manager Regulatory Solutions, in a one hour live webinar on Thursday, August ... in China for drugs and medical devices. Specifically, for medical devices, the NMPA has ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
Breaking Biology Technology:
Cached News: